BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohiuddin IS, Wei SJ, Kang MH. Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochim Biophys Acta Mol Basis Dis 2020;1866:165432. [PMID: 30904611 DOI: 10.1016/j.bbadis.2019.03.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 DiNatale A, Castelli MS, Nash B, Meucci O, Fatatis A. Regulation of Tumor and Metastasis Initiation by Chemokine Receptors. J Cancer 2022;13:3160-76. [PMID: 36118530 DOI: 10.7150/jca.72331] [Reference Citation Analysis]
2 Kulinczak M, Sromek M, Panek G, Zakrzewska K, Lotocka R, Szafron LM, Chechlinska M, Siwicki JK. Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors. Genes 2022;13:1611. [DOI: 10.3390/genes13091611] [Reference Citation Analysis]
3 Tsolou A, Koparanis D, Lamprou I, Giatromanolaki A, Koukourakis MI. Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation. Int J Radiat Biol 2022;:1-15. [PMID: 35976051 DOI: 10.1080/09553002.2022.2113837] [Reference Citation Analysis]
4 Hsu TW, Chen HA, Liao PH, Su YH, Chiu CF, Huang CY, Lin YJ, Hung CC, Yeh MH, Sung SY, Su CM. Dicer-mediated miR-200b expression contributes to cell migratory/invasive abilities and cancer stem cells properties of breast cancer cells. Aging (Albany NY) 2022;14. [PMID: 35951366 DOI: 10.18632/aging.204205] [Reference Citation Analysis]
5 Nayak A, Warrier NM, Kumar P. Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems. Stem Cell Rev Rep 2022. [PMID: 35876959 DOI: 10.1007/s12015-022-10426-9] [Reference Citation Analysis]
6 Sahoo OS, Pethusamy K, Srivastava TP, Talukdar J, Alqahtani MS, Abbas M, Dhar R, Karmakar S. The metabolic addiction of cancer stem cells. Front Oncol 2022;12:955892. [DOI: 10.3389/fonc.2022.955892] [Reference Citation Analysis]
7 Derakhshan S, Mahdavi N, Kardouni Khoozestani N, Nasr Esfahani B, Heidarian F, Rahrotaban S, Abdolrahmani A. Assessment of the association of OCT3/4 with GLUT1 and CD105 in oral squamous cell carcinoma using dual immunohistochemistry. BMC Oral Health 2022;22:300. [PMID: 35854304 DOI: 10.1186/s12903-022-02332-w] [Reference Citation Analysis]
8 Cecchi M, Mannini A, Lapucci A, Silvano A, Lulli M, Luceri C, D’ambrosio M, Chiarugi A, Eid AH, Parenti A. Dexamethasone Promotes a Stem-Like Phenotype in Human Melanoma Cells via Tryptophan 2,3 Dioxygenase. Front Pharmacol 2022;13:911019. [DOI: 10.3389/fphar.2022.911019] [Reference Citation Analysis]
9 Zheng Y, Wang L, Yin L, Yao Z, Tong R, Xue J, Lu Y. Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies. Front Oncol 2022;12:873994. [PMID: 35719973 DOI: 10.3389/fonc.2022.873994] [Reference Citation Analysis]
10 Wang X, Liu Z, Wang Y, Gou S. Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance. J Med Chem . [DOI: 10.1021/acs.jmedchem.2c00472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dai Y, Yu T, Yu C, Lu T, Zhou L, Cheng C, Ni H. ISG15 enhances glioma cell stemness by promoting Oct4 protein stability. Environ Toxicol 2022. [PMID: 35506701 DOI: 10.1002/tox.23556] [Reference Citation Analysis]
12 Filipponi D, Pagnuzzi-Boncompagni M, Pagès G. Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma. Cancers (Basel) 2022;14:2095. [PMID: 35565225 DOI: 10.3390/cancers14092095] [Reference Citation Analysis]
13 Kciuk M, Gielecińska A, Budzinska A, Mojzych M, Kontek R. Metastasis and MAPK Pathways. Int J Mol Sci 2022;23:3847. [PMID: 35409206 DOI: 10.3390/ijms23073847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Paramita P, Preeti A, Mili J, Ridhi J, Mala S, Mm G. Spectrum of Germ Cell Tumor (GCT): 5 Years’ Experience in a Tertiary Care Center and Utility of OCT4 as a Diagnostic Adjunct. Indian J Surg Oncol. [DOI: 10.1007/s13193-022-01522-w] [Reference Citation Analysis]
15 Zheng Y, You H, Duan J, Chen B, Wu C, Chen P, Wang M. Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway. Genes Genomics 2022. [PMID: 35150399 DOI: 10.1007/s13258-021-01215-8] [Reference Citation Analysis]
16 Hagiwara M, Fushimi A, Bhattacharya A, Yamashita N, Morimoto Y, Oya M, Withers HG, Hu Q, Liu T, Liu S, Wong KK, Long MD, Kufe D. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. OncoImmunology 2022;11:2029298. [DOI: 10.1080/2162402x.2022.2029298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
17 Szymonik J, Wala K, Górnicki T, Saczko J, Pencakowski B, Kulbacka J. The Impact of Iron Chelators on the Biology of Cancer Stem Cells. Int J Mol Sci 2021;23:89. [PMID: 35008527 DOI: 10.3390/ijms23010089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Trosko JE. The Concept of "Cancer Stem Cells" in the Context of Classic Carcinogenesis Hypotheses and Experimental Findings. Life (Basel) 2021;11:1308. [PMID: 34947839 DOI: 10.3390/life11121308] [Reference Citation Analysis]
19 Farrar EJ, Hiriart E, Mahmut A, Jagla B, Peal DS, Milan DJ, Butcher JT, Puceat M. OCT4-mediated inflammation induces cell reprogramming at the origin of cardiac valve development and calcification. Sci Adv 2021;7:eabf7910. [PMID: 34739324 DOI: 10.1126/sciadv.abf7910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 You MH, Lee WK, Jin M, Song DE, Cheng SY, Kim TY, Kim WB, Jeon MJ, Kim WG. Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers. Cells 2021;10:2994. [PMID: 34831219 DOI: 10.3390/cells10112994] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Ebrahimie E, Rahimirad S, Tahsili M, Mohammadi-Dehcheshmeh M. Alternative RNA splicing in stem cells and cancer stem cells: Importance of transcript-based expression analysis. World J Stem Cells 2021; 13(10): 1394-1416 [PMID: 34786151 DOI: 10.4252/wjsc.v13.i10.1394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Trosko JE. In Search of a Unifying Concept in Human Diseases. Diseases 2021;9:68. [PMID: 34698126 DOI: 10.3390/diseases9040068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Silva CTX, Saddi VA, Silva KSFE, Sugita DM, Guillo LA. Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma. Melanoma Res 2021;31:439-48. [PMID: 34433195 DOI: 10.1097/CMR.0000000000000767] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Saydé T, Manczak R, Saada S, Bégaud G, Bessette B, Lespes G, Le Coustumer P, Gaudin K, Dalmay C, Pothier A, Lalloué F, Battu S. Characterization of Glioblastoma Cancer Stem Cells Sorted by Sedimentation Field-Flow Fractionation Using an Ultrahigh-Frequency Range Dielectrophoresis Biosensor. Anal Chem 2021;93:12664-71. [PMID: 34491042 DOI: 10.1021/acs.analchem.1c02466] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Xu Y, Mou J, Wang Y, Zhou W, Rao Q, Xing H, Tian Z, Tang K, Wang M, Wang J. Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway. Leukemia 2021. [PMID: 34381181 DOI: 10.1038/s41375-021-01375-2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Qin S, Mao Y, Wang H, Duan Y, Zhao L. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications. Int J Biol Sci 2021;17:2718-36. [PMID: 34345203 DOI: 10.7150/ijbs.60641] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
27 Zhang H, Steed A, Co M, Chen X. Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer. Cancer Drug Resist 2021;4:684-709. [PMID: 34322664 DOI: 10.20517/cdr.2021.32] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Liao M, Wang C, Yang B, Huang D, Zheng Y, Wang S, Wang X, Zhang J, Tang C, Xu Z, He Y, Huang R, Zhang F, Wang Z, Wang N. Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis. Front Pharmacol 2021;12:659297. [PMID: 34149413 DOI: 10.3389/fphar.2021.659297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Mohan A, Raj Rajan R, Mohan G, Kollenchery Puthenveettil P, Maliekal TT. Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells. Front Cell Dev Biol 2021;9:668851. [PMID: 34150761 DOI: 10.3389/fcell.2021.668851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kufe DW. MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment. Carcinogenesis 2020;41:1173-83. [PMID: 32710608 DOI: 10.1093/carcin/bgaa082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
31 Chang Y, Roy S, Pan Z. Store-Operated Calcium Channels as Drug Target in Gastroesophageal Cancers. Front Pharmacol 2021;12:668730. [PMID: 34012400 DOI: 10.3389/fphar.2021.668730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Koshkin SA, Anatskaya OV, Vinogradov AE, Uversky VN, Dayhoff GW 2nd, Bystriakova MA, Pospelov VA, Tolkunova EN. Isolation and Characterization of Human Colon Adenocarcinoma Stem-Like Cells Based on the Endogenous Expression of the Stem Markers. Int J Mol Sci 2021;22:4682. [PMID: 33925224 DOI: 10.3390/ijms22094682] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Mohiuddin IS, Wei SJ, Yang IH, Martinez GM, Yang S, Cho EJ, Dalby KN, Kang MH. Development of cell-based high throughput luminescence assay for drug discovery in inhibiting OCT4/DNA-PKcs and OCT4-MK2 interactions. Biotechnol Bioeng 2021;118:1987-2000. [PMID: 33565603 DOI: 10.1002/bit.27712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Dastmalchi N, Safaralizadeh R, Hosseinpourfeizi MA, Baradaran B, Khojasteh SMB. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation. Mol Biol Rep 2021;48:1345-57. [PMID: 33555529 DOI: 10.1007/s11033-021-06193-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer 2021;20:7. [PMID: 33397409 DOI: 10.1186/s12943-020-01288-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
36 Zhang Q, Han Z, Zhu Y, Chen J, Li W. The Role and Specific Mechanism of OCT4 in Cancer Stem Cells: A Review. Int J Stem Cells 2020;13:312-25. [PMID: 32840233 DOI: 10.15283/ijsc20097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
37 Jiang X, Xing L, Chen Y, Qin R, Song S, Lu Y, Xie S, Wang L, Pu H, Gui X, Li T, Xu J, Li J, Jia S, Lu D. CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells. Mol Ther Nucleic Acids 2021;23:310-23. [PMID: 33425489 DOI: 10.1016/j.omtn.2020.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
38 Zhao X, Lu H, Sun Y, Liu L, Wang H. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis. Medicine (Baltimore) 2020;99:e22804. [PMID: 33080755 DOI: 10.1097/MD.0000000000022804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Litviakov NV, Bychkov VA, Stakheeva MN, Ibragimova MK, Tsyganov MM, Gaptulbarova KA, Tashireva LA, Bondar LN, Garbukov EY, Slonimskaya EM. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins. J Mol Histol 2020;51:717-28. [PMID: 33037978 DOI: 10.1007/s10735-020-09917-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Chacham M, Almoznino G, Zlotogorski-Hurvitz A, Buchner A, Vered M. Expression of stem cell markers in stroma of odontogenic cysts and tumors. J Oral Pathol Med 2020;49:1068-77. [PMID: 32840915 DOI: 10.1111/jop.13102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Ferreira Mendes JM, de Faro Valverde L, Torres Andion Vidal M, Paredes BD, Coelho P, Allahdadi KJ, Coletta RD, Souza BSF, Rocha CAG. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E6487. [PMID: 32899449 DOI: 10.3390/ijms21186487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
42 Liu CL, Chen YJ, Fan MH, Liao YJ, Mao TL. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma. Int J Mol Sci 2020;21:E6467. [PMID: 32899775 DOI: 10.3390/ijms21186467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
43 Roudi R, Barodabi M, Madjd Z, Roviello G, Corona SP, Panahei M. Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients. Mol Cell Oncol 2020;7:1788366. [PMID: 32944642 DOI: 10.1080/23723556.2020.1788366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
44 Huang T, Song X, Xu D, Tiek D, Goenka A, Wu B, Sastry N, Hu B, Cheng SY. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics 2020;10:8721-43. [PMID: 32754274 DOI: 10.7150/thno.41648] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 20.5] [Reference Citation Analysis]
45 Duz MB, Karatas OF. Expression profile of stem cell markers and ABC transporters in 5-fluorouracil resistant Hep-2 cells. Mol Biol Rep 2020;47:5431-8. [PMID: 32627138 DOI: 10.1007/s11033-020-05633-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
46 Clemente-Periván SI, Gómez-Gómez Y, Leyva-Vázquez MA, Lagunas-Martínez A, Organista-Nava J, Illades-Aguiar B. Role of Oct3/4 in Cervical Cancer Tumorigenesis. Front Oncol 2020;10:247. [PMID: 32219062 DOI: 10.3389/fonc.2020.00247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
47 Würth R, Thellung S, Corsaro A, Barbieri F, Florio T. Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells. Front Endocrinol (Lausanne) 2020;11:54. [PMID: 32153500 DOI: 10.3389/fendo.2020.00054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
48 Chien HJ, Ying TH, Hsieh SC, Lin CL, Yu YL, Kao SH, Hsieh YH. α-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis. J Cell Physiol 2020;235:5590-601. [PMID: 31960449 DOI: 10.1002/jcp.29489] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
49 Ye C, Zhang X, Chen X, Cao Q, Zhang X, Zhou Y, Li W, Hong L, Xie H, Liu X, Cao H, Wang YJ, Kang B. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4. Cell Oncol (Dordr) 2020;43:279-95. [PMID: 31848930 DOI: 10.1007/s13402-019-00487-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]